Richard T Kenney - Net Worth and Insider Trading
Richard T Kenney Net Worth
The estimated net worth of Richard T Kenney is at least $5,892 dollars as of 2024-05-27. Richard T Kenney is the Chief Medical Officer of Sonnet BioTherapeutics Holdings Inc and owns about 3,571 shares of Sonnet BioTherapeutics Holdings Inc (SONN) stock worth over $5,892. Details can be seen in Richard T Kenney's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard T Kenney has not made any transactions after 2021-06-09 and currently still holds the listed stock(s).
Transaction Summary of Richard T Kenney
Richard T Kenney Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard T Kenney owns 1 companies in total, including Sonnet BioTherapeutics Holdings Inc (SONN) .
Click here to see the complete history of Richard T Kenney’s form 4 insider trades.
Insider Ownership Summary of Richard T Kenney
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SONN | Sonnet BioTherapeutics Holdings Inc | 2021-06-09 | Chief Medical Officer |
Richard T Kenney Latest Holdings Summary
Richard T Kenney currently owns a total of 1 stock. Richard T Kenney owns 3,571 shares of Sonnet BioTherapeutics Holdings Inc (SONN) as of June 9, 2021, with a value of $5,892.
Latest Holdings of Richard T Kenney
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SONN | Sonnet BioTherapeutics Holdings Inc | 2021-06-09 | 3,571 | 1.65 | 5,892 |
Holding Weightings of Richard T Kenney
Richard T Kenney Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard T Kenney has made a total of 2 transactions in Sonnet BioTherapeutics Holdings Inc (SONN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Sonnet BioTherapeutics Holdings Inc is the acquisition of 1,071 shares on June 9, 2021, which cost Richard T Kenney around $23,100.
Insider Trading History of Richard T Kenney
- 1
Richard T Kenney Trading Performance
GuruFocus tracks the stock performance after each of Richard T Kenney's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard T Kenney is -40.06%. GuruFocus also compares Richard T Kenney's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard T Kenney within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard T Kenney's insider trading performs compared to the benchmark.
Performance of Richard T Kenney
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.81 | | | | | |
| Relative Return to S&P 500(%) | -11.2 | | | | | |
Richard T Kenney Ownership Network
Richard T Kenney Owned Company Details
What does Sonnet BioTherapeutics Holdings Inc do?
Who are the key executives at Sonnet BioTherapeutics Holdings Inc?
Richard T Kenney is the Chief Medical Officer of Sonnet BioTherapeutics Holdings Inc. Other key executives at Sonnet BioTherapeutics Holdings Inc include 10 percent owner John Markey , Chief Technical Officer Susan Dexter , and director & Chairman & President and CEO Pankaj Mohan .
Sonnet BioTherapeutics Holdings Inc (SONN) Insider Trades Summary
Over the past 18 months, Richard T Kenney made no insider transaction in Sonnet BioTherapeutics Holdings Inc (SONN). Other recent insider transactions involving Sonnet BioTherapeutics Holdings Inc (SONN) include a net purchase of 431,600 shares made by Pankaj Mohan , a net purchase of 25,000 shares made by Nailesh Bhatt , and a net purchase of 23,255 shares made by Albert D. Dyrness .
In summary, during the past 3 months, insiders sold 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) were sold and 489,855 shares were bought by its insiders, resulting in a net purchase of 489,855 shares.
Sonnet BioTherapeutics Holdings Inc (SONN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sonnet BioTherapeutics Holdings Inc Insider Transactions
Richard T Kenney Mailing Address
Above is the net worth, insider trading, and ownership report for Richard T Kenney. You might contact Richard T Kenney via mailing address: C/o Immune Design Corp., 1616 Eastlake Ave. E, Suite 310, Seattle Wa 98102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
